Seegene Inc (096530) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.037x

Based on the latest financial reports, Seegene Inc (096530) has a cash flow conversion efficiency ratio of 0.037x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩37.18 Billion ≈ $25.20 Million USD) by net assets (₩1.00 Trillion ≈ $679.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Seegene Inc (096530) defensive interval to measure how many days the company can operate on defensive assets alone.

Seegene Inc - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Seegene Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Seegene Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Seegene Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Hichain Logistics Co Ltd SHE:300873	0.031x
Hefei Department Store Group Co Ltd SHE:000417	0.042x
EnTie Commercial Bank Ltd TW:2849	-0.001x
Omnia Holdings Limited JSE:OMN	0.071x
Ziel Home Furnishing Technology Co. Ltd. A SHE:301376	N/A
Fujian Longxi Bearing Group Co Ltd SHG:600592	0.011x
Zhejiang Whwh SHG:600576	0.061x
MHP SE GDR S/2 F:MPQ	0.056x

Annual Cash Flow Conversion Efficiency for Seegene Inc (2012–2024)

The table below shows the annual cash flow conversion efficiency of Seegene Inc from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Seegene Inc worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩981.48 Billion ≈ $665.13 Million	₩85.39 Billion ≈ $57.87 Million	0.087x	-5.57%
2023-12-31	₩1.03 Trillion ≈ $698.29 Million	₩94.93 Billion ≈ $64.33 Million	0.092x	-66.85%
2022-12-31	₩1.15 Trillion ≈ $777.83 Million	₩319.01 Billion ≈ $216.19 Million	0.278x	-10.02%
2021-12-31	₩1.08 Trillion ≈ $732.85 Million	₩334.02 Billion ≈ $226.36 Million	0.309x	-47.98%
2020-12-31	₩645.32 Billion ≈ $437.32 Million	₩383.16 Billion ≈ $259.66 Million	0.594x	+233.73%
2019-12-31	₩152.55 Billion ≈ $103.38 Million	₩27.14 Billion ≈ $18.39 Million	0.178x	+62.59%
2018-12-31	₩128.03 Billion ≈ $86.76 Million	₩14.01 Billion ≈ $9.49 Million	0.109x	+35.27%
2017-12-31	₩125.04 Billion ≈ $84.74 Million	₩10.12 Billion ≈ $6.86 Million	0.081x	-30.63%
2016-12-31	₩141.97 Billion ≈ $96.21 Million	₩16.56 Billion ≈ $11.22 Million	0.117x	+612.54%
2015-12-31	₩135.09 Billion ≈ $91.55 Million	₩-3.07 Billion ≈ $-2.08 Million	-0.023x	-131.84%
2014-12-31	₩94.83 Billion ≈ $64.27 Million	₩6.78 Billion ≈ $4.59 Million	0.071x	+308.60%
2013-12-31	₩84.44 Billion ≈ $57.23 Million	₩-2.89 Billion ≈ $-1.96 Million	-0.034x	-139.12%
2012-12-31	₩41.94 Billion ≈ $28.42 Million	₩3.67 Billion ≈ $2.49 Million	0.088x	--

About Seegene Inc

KQ:096530 Korea Biotechnology

Market Cap

$900.01 Million

₩1.33 Trillion KRW

Market Cap Rank

#9537 Global

#259 in Korea

Share Price

₩28800.00

Change (1 day)

-2.37%

52-Week Range

₩21850.00 - ₩35150.00

All Time High

₩140042.88